BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:     

ePharma - The Online Pharmaceutical Industry, 2006-2011

ePharma - The Online Pharmaceutical Industry, 2006-2011


The purpose of this visiongain report is to examine the commercial prospects of online technologies in the pharmaceutical sector. In particular, this report examines the fast-growing fields of pharmaceutical eMarketing, eDetailing, ePrescribing and online drug sales. Online technological solutions have great potential to benefit - even revolutionise – the marketing efforts of drug companies. Visiongain predicts that all aspects of pharmaceutical eMarketing will exhibit steady growth from 2006-2011. Key technological solutions - such as Internet-enabled DTC promotion, eDetailing and ePrescribing - will drive that expansion. Sales of prescription drugs via the Internet will also be significant.

ePharma: The Online Pharmaceutical Industry, 2006-2011 examines this burgeoning new method of marketing and the selling of drugs online through comprehensive primary and secondary research. In addition to consultation with experts in eMarketing and ePrescribing, the research involved a detailed study of policy documents, industrial reports and relevant news. Importantly, Visiongain also applied techniques such as financial forecasting, SWOT analyses and qualitative projections. The result is a comprehensive market-based report with detailed analysis and informed opinion.

In particular, this report concentrates on the following essential aspects of online solutions in the pharmaceutical sector:

> Technologies that drive the online pharmaceutical sector

> Key players in eMarketing and ePrescribing – both providers of technology and leading users of these solutions or platforms

> Forecasts of key metrics in eMarketing, ePrescribing and online drug sales from 2006-2011

> Drivers and opportunities in pharmaceutical eMarketing, both to consumers and medical professionals

> Restraints and threats in pharmaceutical eMarketing

> Regulatory issues in pharmaceutical eMarketing, ePrescribing and online drug sales

> Comprehensive assessments of relevant business models, technological solutions and associated issues

Why you should buy this report:

> To receive a comprehensive analysis of the prospects for online solutions in pharmaceutical sales, marketing and prescribing from 2006-2011

> To discover predicted investments, growth rates and other key metrics for online pharmaceutical solutions from 2006-2011

> To determine the forces that influence pharmaceutical eMarketing, ePrescribing and online drug sales: - > Competitive characteristics of the marketRegulatory, technological and societal issues - Drivers and restraints - > Strengths, weaknesses, opportunities and threats

> To find out where pharmaceutical eMarketing, ePrescribing and online drug sales are heading - both technologically and commercially

Lead Analyst: Dr Gordon Low Publication Date: 28/07/06 Pages: 171

Single user licence: The Report is delivered via an on-line reading room. One use access only, the report is in Flash format in a printable format.

Department: Report is delivered via an on line reading room. Five user access only, the report is in Flash format in a printable format.

Company/site wide licence: The report is delivered in email format as a PDF document with no locking system attached. The report can be loaded onto the company's intranet site.
Table of Contents



Price
Single User Licence $2998.00   
Department Licence 5 Users $5998.00   
Company-wide Intranet Licence $9998.00   



Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.

Back to top